| Trade Names: | |
| Synonyms: | |
| Status: | Approved (1940) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| ATC: | R03DA05 |
| UNII: | 27Y3KJK423 |
| InChI Key | FQPFAHBPWDRTLU-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H24N10O4 |
| Molecular Weight | 420.43 |
| AlogP | -1.04 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 0.0 |
| Polar Surface Area | 72.68 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 13.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Cytochrome P450
Cytochrome P450 family 5
Cytochrome P450 family 5A
Cytochrome P450 5A1
|
- | - | - | - | 0-0 | |
|
Enzyme
Phosphodiesterase
Phosphodiesterase 4
Phosphodiesterase 4A
|
- | - | - | - | 34 | |
|
Enzyme
Phosphodiesterase
Phosphodiesterase 4
Phosphodiesterase 4B
|
- | - | - | - | 34 | |
|
Enzyme
Phosphodiesterase
Phosphodiesterase 4
Phosphodiesterase 4C
|
- | - | - | - | 34 | |
|
Enzyme
Phosphodiesterase
Phosphodiesterase 4
Phosphodiesterase 4D
|
- | - | - | - | 34 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Acute Kidney Injury | 3 | D058186 | ClinicalTrials |
| Headache | 3 | D006261 | ClinicalTrials |
| Heart Arrest | 2 | D006323 | ClinicalTrials |
| Hypertension, Pulmonary | 1 | D006976 | ClinicalTrials |
| Premature Birth | 1 | D047928 | ClinicalTrials |
| Altitude Sickness | 1 | D000532 | ClinicalTrials |
| Urinary Bladder Neoplasms | 0 | D001749 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 317-34-0 |
| ChEBI | 2659 |
| ChEMBL | CHEMBL1370561 |
| DrugBank | DB01223 |
| EPA CompTox | DTXSID40883359 |
| FDA SRS | 27Y3KJK423 |
| PharmGKB | PA164781029 |
| PubChem | 9433 |
| SureChEMBL | SCHEMBL5037 |